Elicio Therapeutics

Elicio Therapeutics is a clinical-stage biotechnology company developing novel immunotherapies for the treatment of cancer. By combining expertise in immunology and immunotherapy, Elicio is designing investigational amphiphile (AMP) immunotherapies intended to precisely target and fully engage lymph nodes, which are the sites in our bodies that orchestrate immune responses. Elicio is engineering lymph node-targeting enhancers, immunomodulators, adjuvants, and vaccines for a range of aggressive cancers and infectious diseases.